Nancy Bach

ASSISTANT CLINICAL PROFESSOR Medicine, Liver Diseases

Print Profile

Email

nancy.bach@mssm.edu

Specialty

Gastroenterology-Liver Disease

Certifications

American Board of Internal Medicine

Education

MD, S.U.N.Y, Buffalo - School of Med & Biomed Science
Residency, Internal Medicine
Beth Israel Medical Center
Residency, Internal Medicine
Beth Israel Medical Center
Fellowship, Hepatology/Liver
Mount Sinai Hospital
Fellowship, Gastroenterology
St. Luke's-Roosevelt Hospital Ctr.

Biography

Dr. Bach treats patients with all types of liver disease. She has special research interests in primary biliary cirrhosis and autoimmune hepatitis. She is involved in several epidemiologic studies as well as various studies investigating new treatment options for patients with PBC and autoimmune hepatitis. Patients have the option of seeing Dr. Bach in her New York office located at Mount Sinai or at a satellite office created at Monmouth Medical Center.

Together with Monmouth Medical Center of the Saint Barnabas Health Care System, Mount Sinai and Monmouth Medical Center have created a liver program at Monmouth Medical Center. The Monmouth office is located within the Wound Care Center at Monmouth Medical Center, 255 Third Avenue, Long Branch, New Jersey 07740.

Appointments for both offices are scheduled through the New York office (212) 241-0034.

Research

Primary Biliary Cirrhosis and Autoimmune Hepatitis

Publications

Bach N, Bodian C, Bodenheimer H, Croen E, Berk PD, Thung SN, Lindor K, Therneau T, Schaffner F. Methotrexate therapy for primary biliary cirrhosis. Am J Gastroenterol 2003 Jan; 93(1): 187-93.

Jacobson IM, Ahmed F, Russo MW, Lebovics E, Dietrich DT, Esposito SP, Bach N, Klion F, Tobias H, Antignano L, Robert RS, Gabbaizadeh D, Geders J, Levendoglu H. Interferon Alpha-2b and ribavirin for patients with chronic hepatitis C and normal ALT. Am J Gastroenterol 2004; 99: 1700-1705.

Selmi C, Mayo MJ, Bach N, Invernizzi P, Gish RG, Gordon SC, Wright HI, Zweiban B, Podda M, Gershwin ME. Primary biliary cirrhosis in monozygotic and dizygotic twins: Genetics, epigenetics and environment. Gastroenterol 2004; 127: 485-492.

Stanca C, Bach N, Krause C, Tandon N, Freni M, Gutierrez JA, Bodian C, Lopez J, Berk PD, Bodenheimer HC, Branch AD, Odin JA. Evaluation of fatigue in U.S. patients with primary biliary cirrhosis. Am J Gastroenterol 2005; 100: 1104-1109.

Ala A, Stanca CM, Bu-Ghanim M, Ahmado I, Branch AD, Schiano TD, Odin JA, Bach N. Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology 2006; 43: 525-531.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Bach did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central